PE(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

MIEYBHWKRILIAE-JUUZHAOZSA-N

InChI Key

MIEYBHWKRILIAE-JUUZHAOZSA-N

IUPAC name

Preferred name

PE(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

1-(11Z-octadecenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

ChEBI

CHEBI:137295

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• Flow cytometry has a significant impact on the cellular metabolome (General LC-MS assay)
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_Plasma_vs_WY-14,643_Plasma
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Control_vs_Palmitate
• Ctrl_vs_Ab
• G1_Ctrl_vs_G2_Ab